Invera Wealth Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.26M Sell
4,952
-645
-12% -$150K 0.67% 40
2026
Q1
$1.37M Sell
5,597
-81
-1% -$18.9K 0.88% 37
2025
Q4
$1.18M Sell
5,678
-154
-3% -$30.5K 0.74% 40
2025
Q3
$1.08M Sell
5,832
-7
-0.1% -$1.2K 0.67% 46
2025
Q2
$892K Sell
5,839
-821
-12% -$126K 0.58% 57
2025
Q1
$1.1M Buy
+6,660
New +$1.04M 0.71% 50
2024
Q1
Sell
-6,288
Closed -$986K 83
2023
Q4
$986K Buy
+6,288
New +$964K 0.62% 56

Other funds holding JNJ

Invera Wealth Advisors's JNJ Position: Q2 2026 in Review

Invera Wealth Advisors reduced its Johnson & Johnson (JNJ) stake by 12% in Q2 2026, selling an estimated $150K and leaving 4,952 shares worth $1.26M. The position accounts for 0.67% of the portfolio, ranked #40.

Invera Wealth Advisors first reported a position in JNJ in Q4 2023 and has held it in 7 quarters since. The position peaked at $1.37M in Q1 2026. 4,688 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Invera Wealth Advisors held 4,952 shares of Johnson & Johnson worth $1.26M as of Q2 2026.
  • Invera Wealth Advisors sold 645 Johnson & Johnson shares in Q2 2026, an estimated $150K.
  • Johnson & Johnson made up 0.67% of Invera Wealth Advisors's portfolio in Q2 2026, its #40 holding.
  • Invera Wealth Advisors first reported a position in Johnson & Johnson in Q4 2023 and has held it in 7 quarters since.
  • Invera Wealth Advisors's Johnson & Johnson position peaked at $1.37M in Q1 2026.
  • 4,688 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Invera Wealth Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.